Published in J Transl Med on December 17, 2012
Immunotherapy for brain cancer: recent progress and future promise. Clin Cancer Res (2014) 0.99
Do relevant markers of cancer stem cells CD133 and Nestin indicate a poor prognosis in glioma patients? A systematic review and meta-analysis. J Exp Clin Cancer Res (2015) 0.97
Emerging biomarkers in glioblastoma. Cancers (Basel) (2013) 0.96
The prognostic value of Foxp3+ tumor-infiltrating lymphocytes in patients with glioblastoma. J Neurooncol (2013) 0.91
Regulation of expression of O6-methylguanine-DNA methyltransferase and the treatment of glioblastoma (Review). Int J Oncol (2015) 0.87
microRNA expression pattern modulates temozolomide response in GBM tumors with cancer stem cells. Cell Mol Neurobiol (2014) 0.86
CD133 Expression Is Not Synonymous to Immunoreactivity for AC133 and Fluctuates throughout the Cell Cycle in Glioma Stem-Like Cells. PLoS One (2015) 0.86
Prognostic impact of MGMT promoter methylation and MGMT and CD133 expression in colorectal adenocarcinoma. BMC Cancer (2014) 0.84
Decoding the cancer stem cell hypothesis in glioblastoma. CNS Oncol (2013) 0.82
A novel approach to the discovery of survival biomarkers in glioblastoma using a joint analysis of DNA methylation and gene expression. Epigenetics (2014) 0.82
Correlation of altered expression of the autophagy marker LC3B with poor prognosis in astrocytoma. Biomed Res Int (2014) 0.80
Temozolomide Resistance in Glioblastoma Cell Lines: Implication of MGMT, MMR, P-Glycoprotein and CD133 Expression. PLoS One (2015) 0.80
Olea europaea leaf extract improves the treatment response of GBM stem cells by modulating miRNA expression. Am J Cancer Res (2014) 0.79
Inhibition of DNA-repair genes Ercc1 and Mgmt enhances temozolomide efficacy in gliomas treatment: a pre-clinical study. Oncotarget (2015) 0.77
Characterization of a novel anti-cancer compound for astrocytomas. PLoS One (2014) 0.75
Molecular-Based Recursive Partitioning Analysis Model for Glioblastoma in the Temozolomide Era: A Correlative Analysis Based on NRG Oncology RTOG 0525. JAMA Oncol (2017) 0.75
Is the prognostic significance of O6-methylguanine- DNA methyltransferase promoter methylation equally important in glioblastomas of patients from different continents? A systematic review with meta-analysis. Cancer Manag Res (2017) 0.75
Base excision repair imbalance in colorectal cancer has prognostic value and modulates response to chemotherapy. Oncotarget (2017) 0.75
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med (2005) 74.55
Stem cells, cancer, and cancer stem cells. Nature (2001) 50.27
MGMT gene silencing and benefit from temozolomide in glioblastoma. N Engl J Med (2005) 29.65
Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature (2006) 27.91
Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol (2009) 25.96
Identification of a cancer stem cell in human brain tumors. Cancer Res (2003) 24.02
Response criteria for phase II studies of supratentorial malignant glioma. J Clin Oncol (1990) 18.71
Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents. N Engl J Med (2000) 12.34
Direct isolation of human central nervous system stem cells. Proc Natl Acad Sci U S A (2000) 10.88
Analysis of gene expression and chemoresistance of CD133+ cancer stem cells in glioblastoma. Mol Cancer (2006) 8.50
Stem cell-related "self-renewal" signature and high epidermal growth factor receptor expression associated with resistance to concomitant chemoradiotherapy in glioblastoma. J Clin Oncol (2008) 6.41
Phase III trial of chemotherapy plus radiotherapy compared with radiotherapy alone for pure and mixed anaplastic oligodendroglioma: Intergroup Radiation Therapy Oncology Group Trial 9402. J Clin Oncol (2006) 4.88
Molecular predictors of progression-free and overall survival in patients with newly diagnosed glioblastoma: a prospective translational study of the German Glioma Network. J Clin Oncol (2009) 3.65
MGMT promoter methylation in malignant gliomas: ready for personalized medicine? Nat Rev Neurol (2009) 3.32
Correlation between O6-methylguanine-DNA methyltransferase and survival in inoperable newly diagnosed glioblastoma patients treated with neoadjuvant temozolomide. J Clin Oncol (2007) 3.23
Stem cell marker CD133 affects clinical outcome in glioma patients. Clin Cancer Res (2008) 3.22
Clinical and biological implications of CD133-positive and CD133-negative cells in glioblastomas. Lab Invest (2008) 2.79
Cancer stem cell analysis and clinical outcome in patients with glioblastoma multiforme. Clin Cancer Res (2008) 2.52
Extent of MGMT promoter methylation correlates with outcome in glioblastomas given temozolomide and radiotherapy. Br J Cancer (2009) 2.01
Recurrence pattern after temozolomide concomitant with and adjuvant to radiotherapy in newly diagnosed patients with glioblastoma: correlation With MGMT promoter methylation status. J Clin Oncol (2009) 1.95
CpG island hypermethylation of the DNA repair enzyme methyltransferase predicts response to temozolomide in primary gliomas. Clin Cancer Res (2004) 1.92
Anti-O6-methylguanine-methyltransferase (MGMT) immunohistochemistry in glioblastoma multiforme: observer variability and lack of association with patient survival impede its use as clinical biomarker. Brain Pathol (2008) 1.74
MGMT promoter methylation is predictive of response to radiotherapy and prognostic in the absence of adjuvant alkylating chemotherapy for glioblastoma. Neuro Oncol (2009) 1.69
Nestin and CD133: valuable stem cell-specific markers for determining clinical outcome of glioma patients. J Exp Clin Cancer Res (2008) 1.58
CD133 expression and cancer stem cells predict prognosis in high-grade oligodendroglial tumors. Brain Pathol (2008) 1.56
MGMT prognostic impact on glioblastoma is dependent on therapeutic modalities. J Neurooncol (2007) 1.42
MGMT immunohistochemical expression and promoter methylation in human glioblastoma. Appl Immunohistochem Mol Morphol (2008) 1.40
O-methylguanine-DNA methyltransferase (MGMT) mRNA expression predicts outcome in malignant glioma independent of MGMT promoter methylation. PLoS One (2011) 1.32
Reduction of the toxicity and mutagenicity of alkylating agents in mammalian cells harboring the Escherichia coli alkyltransferase gene. Proc Natl Acad Sci U S A (1986) 1.31
MGMT gene promoter methylation as a potent prognostic factor in glioblastoma treated with temozolomide-based chemoradiotherapy: a single-institution study. Int J Radiat Oncol Biol Phys (2012) 1.31
O(6)-methylguanine DNA-methyltransferase methylation status can change between first surgery for newly diagnosed glioblastoma and second surgery for recurrence: clinical implications. Neuro Oncol (2010) 1.30
Recent advances in the molecular understanding of glioblastoma. J Neurooncol (2012) 1.29
Comprehensive analysis of MGMT promoter methylation: correlation with MGMT expression and clinical response in GBM. PLoS One (2011) 1.27
Current therapeutic paradigms in glioblastoma. Rev Recent Clin Trials (2010) 1.24
Prognostic value of three different methods of MGMT promoter methylation analysis in a prospective trial on newly diagnosed glioblastoma. PLoS One (2012) 1.19
Correlation of clinical features and methylation status of MGMT gene promoter in glioblastomas. J Neurooncol (2004) 1.17
The presence of stem cell marker-expressing cells is not prognostically significant in glioblastomas. Neuropathology (2011) 1.16
Pitfalls in the assessment of MGMT expression and in its correlation with survival in diffuse astrocytomas: proposal of a feasible immunohistochemical approach. Acta Neuropathol (2007) 1.13
The correlation and prognostic significance of MGMT promoter methylation and MGMT protein in glioblastomas. Neurosurgery (2009) 1.09
Correlation between O6-methylguanine-DNA methyltransferase and survival in elderly patients with glioblastoma treated with radiotherapy plus concomitant and adjuvant temozolomide. J Neurooncol (2010) 1.08
Expression of the stem cell marker CD133 in recurrent glioblastoma and its value for prognosis. Cancer (2010) 1.07
Immunohistochemical study for O6-methylguanine-DNA methyltransferase in the non-neoplastic and neoplastic components of gliomas. J Neurooncol (2004) 1.07
Relevance of MSP assay for the detection of MGMT promoter hypermethylation in glioblastomas. Int J Oncol (2008) 1.02
Prognostic impact of CD133 mRNA expression in 48 glioblastoma patients treated with concomitant radiochemotherapy: a prospective patient cohort at a single institution. Ann Surg Oncol (2011) 1.01
Correlation of MGMT promoter methylation status with gene and protein expression levels in glioblastoma. Clinics (Sao Paulo) (2011) 0.99
Prognostic significance of the immunohistochemical expression of O6-methylguanine-DNA methyltransferase, P-glycoprotein, and multidrug resistance protein-1 in glioblastomas. Neuropathology (2008) 0.95
O(6)-Methylguanine DNA methyltransferase determined by promoter hypermethylation and immunohistochemical expression is correlated with progression-free survival in patients with glioblastoma. Int J Clin Oncol (2010) 0.94
Quantitative digital assessment of MGMT immunohistochemical expression in glioblastoma tissue. Brain Tumor Pathol (2011) 0.91
Clinical correlation of MGMT protein expression and promoter methylation in Chinese glioblastoma patients. Med Oncol (2011) 0.87
O6-methylguanine DNA methyltransferase expression in tumor cells predicts outcome of radiotherapy plus concomitant and adjuvant temozolomide therapy in patients with primary glioblastoma. Brain Tumor Pathol (2011) 0.86
Prognostic significance of loss of O6-methylguanine-DNA methyltransferase expression in supratentorial diffuse low-grade astrocytoma. Surg Neurol (2007) 0.85
Pathological findings and prognostic factors in recurrent glioblastomas. Brain Tumor Pathol (2012) 0.84
ESCRT-II, an endosome-associated complex required for protein sorting: crystal structure and interactions with ESCRT-III and membranes. Dev Cell (2004) 2.86
[Does body mass index influence mortality in patients with heart failure?]. Rev Esp Cardiol (2007) 2.73
[Prevalence of anemia and its correlation with clinical parameters in patients from a multidisciplinary heart failure unit]. Med Clin (Barc) (2004) 2.02
[Noninvasive remote telemonitoring for ambulatory patients with heart failure: effect on number of hospitalizations, days in hospital, and quality of life. CARME (CAtalan Remote Management Evaluation) study]. Rev Esp Cardiol (2011) 1.72
Immune infiltrates are prognostic factors in localized gastrointestinal stromal tumors. Cancer Res (2013) 1.58
Orbicularis oris muscle defects as an expanded phenotypic feature in nonsyndromic cleft lip with or without cleft palate. Am J Med Genet A (2007) 1.48
Consensus of the Spanish Society of Medical Oncology (SEOM) and Spanish Society of Pathology (SEAP) for HER2 testing in gastric carcinoma. Clin Transl Oncol (2011) 1.46
[Prognostic significance of hemoglobin levels in patients with heart failure]. Rev Esp Cardiol (2005) 1.45
Microbiological contamination in stem cell cultures. Cell Biol Int (2007) 1.43
[Prognostic significance of diabetes in a heart failure population: one year mortality and heart failure related hospital admission]. Med Clin (Barc) (2005) 1.42
[Factors influencing mobilisation of endothelial progenitor cells and angiogenic cytokines after an extensive acute myocardial infarction]. Med Clin (Barc) (2011) 1.39
[Clinical, echocardiographic and prognostic evaluation of atrial fibrillation in patients with heart failure]. Med Clin (Barc) (2007) 1.38
A tree-based conservation scoring method for short linear motifs in multiple alignments of protein sequences. BMC Bioinformatics (2008) 1.35
Dietary olive oil supplemented with fish oil, rich in EPA and DHA (n-3) polyunsaturated fatty acids, attenuates colonic inflammation in rats with DSS-induced colitis. J Nutr (2005) 1.18
Prognostic implication of frailty and depressive symptoms in an outpatient population with heart failure. Rev Esp Cardiol (2008) 1.17
Implication of the β2-microglobulin gene in the generation of tumor escape phenotypes. Cancer Immunol Immunother (2012) 1.15
Microbiological control in stem cell banks: approaches to standardisation. Appl Microbiol Biotechnol (2005) 1.14
Preventative effects of a probiotic, Lactobacillus salivarius ssp. salivarius, in the TNBS model of rat colitis. World J Gastroenterol (2005) 1.12
Crystal structures of Paenibacillus polymyxa beta-glucosidase B complexes reveal the molecular basis of substrate specificity and give new insights into the catalytic machinery of family I glycosidases. J Mol Biol (2007) 1.11
Heme oxygenase-1 levels and oxidative stress-related parameters in non-alcoholic fatty liver disease patients. J Hepatol (2005) 1.09
Combined use of high-sensitivity ST2 and NTproBNP to improve the prediction of death in heart failure. Eur J Heart Fail (2012) 1.08
The intestinal anti-inflammatory effect of quercitrin is associated with an inhibition in iNOS expression. Br J Pharmacol (2004) 1.07
Structural and kinetic analysis of Schwanniomyces occidentalis invertase reveals a new oligomerization pattern and the role of its supplementary domain in substrate binding. J Biol Chem (2010) 1.06
Dietary fiber down-regulates colonic tumor necrosis factor alpha and nitric oxide production in trinitrobenzenesulfonic acid-induced colitic rats. J Nutr (2002) 1.01
Lactobacillus fermentum, a probiotic capable to release glutathione, prevents colonic inflammation in the TNBS model of rat colitis. Int J Colorectal Dis (2005) 0.99
A comparative study of the preventative effects exerted by two probiotics, Lactobacillus reuteri and Lactobacillus fermentum, in the trinitrobenzenesulfonic acid model of rat colitis. Br J Nutr (2007) 0.98
Buthionine sulfoximine increases the toxicity of nifurtimox and benznidazole to Trypanosoma cruzi. Antimicrob Agents Chemother (2005) 0.98
Conventional and molecular cytogenetic diagnostic methods in stem cell research: a concise review. Cell Biol Int (2007) 0.98
Patients' self-care improvement with nurse education intervention in Spain assessed by the European Heart Failure Self-Care Behaviour Scale. Eur J Cardiovasc Nurs (2007) 0.96
Preventative effects of lactulose in the trinitrobenzenesulphonic acid model of rat colitis. Inflamm Bowel Dis (2005) 0.94
The development of 'feeder' cells for the preparation of clinical grade hES cell lines: challenges and solutions. J Biotechnol (2006) 0.94
Effects of periodontal therapy on systemic markers of inflammation in patients with metabolic syndrome: a controlled clinical trial. J Periodontol (2011) 0.91
Analysis of NK cells and chemokine receptors in tumor infiltrating CD4 T lymphocytes in human renal carcinomas. Cancer Immunol Immunother (2005) 0.91
Depression, antidepressants, and long-term mortality in heart failure. Int J Cardiol (2012) 0.91
Structural insights into the specificity of Xyn10B from Paenibacillus barcinonensis and its improved stability by forced protein evolution. J Biol Chem (2009) 0.91
A2B adenosine receptor mediates human chorionic vasoconstriction and signals through arachidonic acid cascade. Am J Physiol Heart Circ Physiol (2005) 0.90
Periodontal disease epidemiology - learned and unlearned? Periodontol 2000 (2013) 0.90
Blood metals concentration in type 1 and type 2 diabetics. Biol Trace Elem Res (2013) 0.90
Oligosaccharides isolated from goat milk reduce intestinal inflammation in a rat model of dextran sodium sulfate-induced colitis. Clin Nutr (2006) 0.90
CNK/T-cell brain lymphoma associated with Epstein-Barr virus in a patient with AIDS. Neuropathology (2007) 0.88
Evaluation of a telemedicine system for heart failure patients: feasibility, acceptance rate, satisfaction and changes in patient behavior: results from the CARME (CAtalan Remote Management Evaluation) study. Eur J Cardiovasc Nurs (2012) 0.88
Three-dimensional structure of Saccharomyces invertase: role of a non-catalytic domain in oligomerization and substrate specificity. J Biol Chem (2013) 0.88
New gene therapy strategies for cancer treatment: a review of recent patents. Recent Pat Anticancer Drug Discov (2012) 0.87
5-Fluorouracil derivatives: a patent review. Expert Opin Ther Pat (2012) 0.87
Patient-acceptable symptom state as an outcome measure in the daily care of patients with ankylosing spondylitis. J Rheumatol (2012) 0.87
Review article: relationship of human papillomavirus with papillary squamous cell carcinoma of the upper aerodigestive tract: a review. Int J Surg Pathol (2008) 0.87
Quality of life monitoring in ambulatory heart failure patients: temporal changes and prognostic value. Eur J Heart Fail (2012) 0.86
Basal cell carcinoma in childhood after radiation therapy: case report and review. Ann Plast Surg (2004) 0.86
Doxorubicin-loaded nanoparticles: new advances in breast cancer therapy. Anticancer Agents Med Chem (2012) 0.86
Human cardiac tissue induces transdifferentiation of adult stem cells towards cardiomyocytes. Cytotherapy (2010) 0.86
Post-epizootic chronic dolphin morbillivirus infection in Mediterranean striped dolphins Stenella coeruleoalba. Dis Aquat Organ (2011) 0.86
Serum cytokine profile in patients with pancreatic cancer. Pancreas (2014) 0.86
Cancer stem cells and their implication in breast cancer. Eur J Clin Invest (2014) 0.86
The EBI enzyme portal. Nucleic Acids Res (2012) 0.86
Human Papillomavirus (HPV) Type Distribution in Females with Abnormal Cervical Cytology. A Correlation with Histological Study. Open Virol J (2009) 0.86
Conformational changes in inositol 1,3,4,5,6-pentakisphosphate 2-kinase upon substrate binding: role of N-terminal lobe and enantiomeric substrate preference. J Biol Chem (2012) 0.85
Defining a periodontitis case: analysis of a never-treated adult population. J Clin Periodontol (2011) 0.85
Socio-demographic, clinical and treatment characteristics of relapsing schizophrenic patients. Nord J Psychiatry (2012) 0.85
Exploring changes in dental workforce, dental care utilisation and dental caries levels in Europe, 1990-2004. Int Dent J (2009) 0.85
Environmental monitoring in stem cell banks. Appl Microbiol Biotechnol (2006) 0.85
Ex vivo impact of functionalized carbon nanotubes on human immune cells. Nanomedicine (Lond) (2011) 0.85
Serum myostatin levels in chronic heart failure. Rev Esp Cardiol (2010) 0.84
Assessment of reference ranges for blood Cu, Mn, Se and Zn in a selected Italian population. J Trace Elem Med Biol (2011) 0.84
Toxic epidermal necrolysis secondary to timolol, dorzolamide, and latanoprost eyedrops. J Am Acad Dermatol (2005) 0.84
[Use of the Minnesota Living With Heart Failure Quality of Life Questionnaire in Spain]. Rev Esp Cardiol (2004) 0.84
Prognostic impact of MGMT promoter methylation and MGMT and CD133 expression in colorectal adenocarcinoma. BMC Cancer (2014) 0.84
The chemotherapeutic drug 5-fluorouracil promotes PKR-mediated apoptosis in a p53-independent manner in colon and breast cancer cells. PLoS One (2011) 0.84
Application of nanotechnology in the treatment and diagnosis of gastrointestinal cancers: review of recent patents. Recent Pat Anticancer Drug Discov (2014) 0.84
Nanomedicine: application areas and development prospects. Int J Mol Sci (2011) 0.84
Crystal structure and functional insights into uracil-DNA glycosylase inhibition by phage Φ29 DNA mimic protein p56. Nucleic Acids Res (2013) 0.83
RNA interference in the treatment of colon cancer. BioDrugs (2013) 0.83
Growth inhibition, G(1)-arrest, and apoptosis in MCF-7 human breast cancer cells by novel highly lipophilic 5-fluorouracil derivatives. Invest New Drugs (2004) 0.83
Novel drug delivery system based on docetaxel-loaded nanocapsules as a therapeutic strategy against breast cancer cells. Int J Mol Sci (2012) 0.83
Crystallization and preliminary X-ray diffraction analysis of inositol 1,3,4,5,6-pentakisphosphate kinase from Arabidopsis thaliana. Acta Crystallogr Sect F Struct Biol Cryst Commun (2009) 0.83
Equity in children's utilization of dental services: effect of a children's dental care programme. Community Dent Health (2006) 0.83
Anti-inflammatory, antinociceptive, and antipyretic effects of Lantana trifolia Linnaeus in experimental animals. Invest Clin (2004) 0.83
Cadmium modifies the cell cycle and apoptotic profiles of human breast cancer cells treated with 5-fluorouracil. Int J Mol Sci (2013) 0.83
Multidrug resistance and rhabdomyosarcoma (Review). Oncol Rep (2011) 0.83
Functionalized nanostructures with application in regenerative medicine. Int J Mol Sci (2012) 0.83
5-fluorouracil derivatives induce differentiation mediated by tubulin and HLA class I modulation. Med Chem (2007) 0.83
Airborne particle monitoring in clean room environments for stem cell cultures. Biotechnol J (2008) 0.83
A polymorphism in the interleukin-10 promoter affects the course of disease in patients with clear-cell renal carcinoma. Hum Immunol (2008) 0.82
Exogenous nucleosides modulate proliferation of rat intestinal epithelial IEC-6 cells. J Nutr (2007) 0.82
DNA methylation plasticity of human adipose-derived stem cells in lineage commitment. Am J Pathol (2012) 0.82
Hypertrophic infantile pedal papules. Pediatr Dermatol (2007) 0.82
Sex and age differences in fragility in a heart failure population. Eur J Heart Fail (2005) 0.82
ESR1 gene promoter region methylation in free circulating DNA and its correlation with estrogen receptor protein expression in tumor tissue in breast cancer patients. BMC Cancer (2014) 0.82
Carbohydrate 19.9 antigen serum levels in liver disease. Biomed Res Int (2013) 0.82
Capsular origin of the long head of the biceps brachii tendon: a clinical case. Rom J Morphol Embryol (2010) 0.82
Structural and kinetic insights reveal that the amino acid pair Gln-228/Asn-254 modulates the transfructosylating specificity of Schwanniomyces occidentalis β-fructofuranosidase, an enzyme that produces prebiotics. J Biol Chem (2012) 0.81